Henry Z. Markus
14Patents
9h-index
18Co-inventors
69Inventor score
Filing activity: Feb 23, 1978 → Jul 19, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4337242A | Vaccine stabilizer containing L-glutamic acid and L-arginine | Emerging Cross-Sectional Technologies | 64 | Expired |
| US4338335A | Vaccine stabilizer containing L-glutamic acid and L-arginine | Emerging Cross-Sectional Technologies | 36 | Expired |
| US4416986A | Methods of producing HBsAg | Chemistry; Metallurgy | 24 | Expired |
| US4147772A | Vaccine stabilizer | Emerging Cross-Sectional Technologies | 22 | Expired |
| US6291205A | Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae | Chemistry; Metallurgy | 19 | Expired |
| US4273762A | Lyophilization process for live viral compositions | Chemistry; Metallurgy | 16 | Expired |
| US5024836A | Stable lyophilized live herpes virus vaccine | Chemistry; Metallurgy | 15 | Expired |
| US5888516A | Recombinant papillomavirus vaccines | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4301249A | High titer production of hepatitis A virus | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4301250A | Method of producing hepatitis B surface antigen | Chemistry; Metallurgy | 5 | Expired |
| US7276243B2 | Optimized expression of HPV31 L1 in yeast | Chemistry; Metallurgy | 3 | Expired |
| US4288539A | Bacterial or bacterial antibody assay | Emerging Cross-Sectional Technologies | 3 | Expired |
| US4412002A | Process for preparing hepatitis A virus | Chemistry; Metallurgy | 2 | Expired |
| US7482428B2 | Optimized expression of HPV 31 L1 in yeast | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.